Prepaid Expenses and Other Current Assets and Accrued Expenses (Tables)

9 Months Ended

Sep. 30, 2026

Payables and Accruals [Abstract]

Schedule of Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consisted of the following as of September 30, 2026 and December 31, 2025 (in thousands):


		September 30, 2026				December 31, 2025
CRO advances and prepaid clinical trial expenses		$	38,694			$	11,507
Other prepaid expenses and other current assets			4,668				1,712
Total prepaid expenses and other current assets		$	43,362			$	13,219

Schedule of Accrued Expenses

Accrued expenses consisted of the following as of September 30, 2026 and December 31, 2025 (in thousands):


		September 30, 2026				December 31, 2025
Accrued CRO costs		$	15,331			$	1,324
Accrued research and development costs			1,191				449
Accrued compensation costs			3,330				1,680
Accrued professional and consulting costs			1,849				350
Accrued termination benefits and other accrued costs			709				782
Total accrued expenses		$	22,410			$	4,585